BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazzolai L, Ageno W, Alatri A, Bauersachs R, Becattini C, Brodmann M, Emmerich J, Konstantinides S, Meyer G, Middeldorp S, Monreal M, Righini M, Aboyans V. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function. Eur J Prev Cardiol 2021:zwab088. [PMID: 34254133 DOI: 10.1093/eurjpc/zwab088] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Ayyoub S, Orriols R, Oliver E, Ceide OT. Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis. IJMS 2023;24:2569. [DOI: 10.3390/ijms24032569] [Reference Citation Analysis]
2 Kaperiz KA, Rastatueva AO, Yavelov IS, Drapkina OM. Comparison of endovenous laser ablation and conservative treatment in acute thrombophlebitis of the varicose great saphenous vein: rationale, design and first results of clinical trial. Cardiovasc Ther Prev 2023;21:3461. [DOI: 10.15829/1728-8800-2022-3461] [Reference Citation Analysis]
3 Yavelov IS. Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account? Aterotromboz 2023;12:22-31. [DOI: 10.21518/2307-1109-2022-12-2] [Reference Citation Analysis]
4 Lopez-Ruz S, Barca-Hernando M, Marin-Romero S, Elias-Hernandez T, Otero-Candelera R, Jara-Palomares L. Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis. Br J Cancer 2022;127:2234-40. [PMID: 36241715 DOI: 10.1038/s41416-022-02007-x] [Reference Citation Analysis]
5 Bauersachs R. Antikoagulation bei Thrombose und Lungenembolie. Aktuelle Kardiologie 2022;11:543-550. [DOI: 10.1055/a-1952-2377] [Reference Citation Analysis]
6 Wenger N, Sebastian T, Beer JH, Mazzolai L, Aujesky D, Hayoz D, Engelberger RP, Korte W, Voci D, Kucher N, Barco S, Spirk D. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER). Thrombosis Research 2022;220:65-71. [DOI: 10.1016/j.thromres.2022.10.006] [Reference Citation Analysis]
7 Ageno W, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Visonà A, Bigagli E, Palareti G. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ 2022. [DOI: 10.1136/bmj-2022-072623] [Reference Citation Analysis]
8 Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022;43:4229-361. [PMID: 36017568 DOI: 10.1093/eurheartj/ehac244] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 65.0] [Reference Citation Analysis]
9 Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging 2022:jeac106. [PMID: 36017575 DOI: 10.1093/ehjci/jeac106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shi M, Gao W, Jin Y, Zhu J, Liu Y, Wang T, Li C. Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.872523] [Reference Citation Analysis]
11 Vacula I, Rusiňáková Z, Čelovská D, Jackuliak P, Slopovský J, Palacka P, Moščovič M, Špánik S, Staško J, Wild A, Bátorová A, Maďarič J. Prevention and treatment of cancer associated venous thromboembolism - interdisciplinary consensus. Vnitr Lek 2022;68:221-226. [DOI: 10.36290/vnl.2022.047] [Reference Citation Analysis]
12 Bauersachs R. Beinvenenthrombose und Lungenembolie: Diagnostik und Therapie. Internist. [DOI: 10.1007/s00108-022-01349-1] [Reference Citation Analysis]
13 Middeldorp S, Naue C, Köhler C. Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom? Hamostaseologie 2022;42:54-64. [PMID: 35196731 DOI: 10.1055/a-1717-7663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Yavelov IS, Kaperiz KA, Drapkina OM. Anticoagulants in the treatment of superficial vein thrombosis of lower limbs: possibilities and limitations. Aterotromboz 2022;11:94-102. [DOI: 10.21518/2307-1109-2021-11-2-94-102] [Reference Citation Analysis]
15 Jain N, Avanthika C, Singh A, Jhaveri S, De la Hoz I, Hassen G, Camacho L GP, Carrera KG. Deep Vein Thrombosis in Intravenous Drug Users: An Invisible Global Health Burden. Cureus 2021;13:e18457. [PMID: 34745781 DOI: 10.7759/cureus.18457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Vrints CJM. Deep venous thrombosis and endothelial dysfunction in cancer: prevention and early initiated rehabilitation should be integral to a cardio-oncology programme. Eur J Prev Cardiol 2021:zwab117. [PMID: 34463767 DOI: 10.1093/eurjpc/zwab117] [Reference Citation Analysis]